Zynlonta Patient - r/r DLBCL Treatment | ZYNLONTA® …
ZYNLONTA ® is a prescription medicine used to treat adults with certain types of large B-cell lymphoma that has come back (relapsed) or that did not respond to previous treatment …
Loncastuximab tesirine - Wikipedia
Loncastuximab tesirine, sold under the brand name Zynlonta, is a monoclonal antibody conjugate medication used to treat large B-cell lymphoma and high-grade B-cell lymphoma. [1] [2] It is an …
R/R DLBCL Treatment | ZYNLONTA® (loncastuximab tesirine-lpyl) …
2022年4月1日 · ZYNLONTA ® is indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse …
Zynlonta: Uses, Dosage, Side Effects, Warnings - Drugs.com
2024年8月22日 · Zynlonta is a prescription medicine used to treat adults with certain types of large B-cell lymphoma that has come back (relapsed) or that did not respond to previous …
Zynlonta Patient Brochure
ZYNLONTA ® (loncastuximab tesirine-lypl) is a prescription medicine used to treat adults with certain types of large B-cell lymphoma that has come back (relapsed) or that did not respond …
Dosing | ZYNLONTA® (loncastuximab tesirine-lpyl) HCP Site
ZYNLONTA ® is indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell …
What is ZYNLONTA? ZYNLONTA is a prescription medicine used to treat adults with certain types of large B-cell lymphoma that has come back (relapsed) or that did not respond to …
DailyMed - ZYNLONTA- loncastuximab tesirine injection, powder ...
2024年7月12日 · ZYNLONTA is indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse …
ZYNLONTA® (loncastuximab tesirine-lpyl) Patient Site - Zynlonta …
ZYNLONTA ® is a prescription medicine used to treat adults with certain types of large B-cell lymphoma that has come back (relapsed) or that did not respond to previous treatment …
Zynlonta - European Medicines Agency (EMA)
2023年1月26日 · Zynlonta is a medicine for treating two types of B-cell lymphoma (a type of blood cancer): diffuse large B-cell lymphoma (DLBCL); high-grade B-cell lymphoma (HGBL).